Kineta, Inc., a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced that the company will participate in a virtual H.C. Wainwright @Home Fireside Chat Series on February 13, 2024.
February 7, 2024
· 5 min read
